The New Buy-Side Collateral Equation
Most buy-side firms are just beginning the process of understanding how central clearing of OTC derivatives will impact their trading decisions. From trade certainty to margin volatility, firms need the front- to back-office data and the tools to calculate their funding positions, understand the true cost of a trade, and source and deliver collateral efficiently. TABB Group director of fixed income research Will Rhode and Sol Steinberg, founder of OTC Partners, discuss the changing buy-side collateral equation and the technology solutions that firms need to meet this challenge.